Physician profile
David Hou
NPI 1346342706
$13,844.27
in general payments reported to CMS, 2019-2025
10 companies · $2,648 in 2025
The $2,648 reported for 2025 was more than what 87% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,217 · 2020: $662 · 2021: $1,543 · 2022: $1,545 · 2023: $2,271 · 2024: $2,959 · 2025: $2,648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,877.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $6,229.92 | 2019-2024 | Senza |
| Medtronic, INC. | $3,649.35 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $1,132.77 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $908.35 | 2024-2025 | Eterna, Proclaim |
| Globus Medical, INC. | $830.38 | 2025 | Senza, Omnia |
| Medtronic USA, INC. | $357.87 | 2019-2020 | |
| Saluda Medical Americas, INC. | $299.99 | 2025 | Evoke |
| Relievant Medsystems, INC. | $183.69 | 2023 | Intracept |
| Stryker Corporation | $174.85 | 2022 | |
| Nalu Medical, INC. | $77.10 | 2025 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.